<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://physiolgenomics.physiology.org">
<title>Physiological Genomics recent issues</title>
<link>http://physiolgenomics.physiology.org</link>
<description>Physiological Genomics RSS feed -- recent issues</description>
<prism:eIssn>1531-2267</prism:eIssn>
<prism:publicationName>Physiological Genomics</prism:publicationName>
<prism:issn>1094-8341</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/1?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/full/34/1/6?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/9?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/22?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/34?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/42?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/54?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/65?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/78?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/88?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/95?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/101?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/112?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/127?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/301?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/312?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/323?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/333?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/341?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/355?rss=1" />
  <rdf:li rdf:resource="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/361?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://physiolgenomics.physiology.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://physiolgenomics.physiology.org/icons/banner/title.gif">
<title>Physiological Genomics</title>
<url>http://physiolgenomics.physiology.org/icons/banner/title.gif</url>
<link>http://physiolgenomics.physiology.org</link>
</image>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/1?rss=1">
<title><![CDATA[Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding?]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/1?rss=1</link>
<description><![CDATA[
<P>Metabolomics aims to profile all the small molecule metabolites found within a cell, tissue, organ, or organism and use this information to understand a biological manipulation such as a drug intervention or a gene knockout. While neither mass spectrometry or NMR spectroscopy, the two most commonly used analytical tools in metabolomics, can provide a complete coverage of the metabolome, compared with other functional genomic tools for profiling biological moieties the approach is cheap and high throughput. In diabetes and obesity research this has provided the opportunity to assess large human populations or investigate a range of different tissues in animal studies both rapidly and cheaply. However, the approach has a number of major challenges, particularly with the interpretation of the data obtained. For example, some key pathways are better represented by high concentration metabolites inside the cell, and thus, the coverage of the metabolome may become biased towards these pathways (e.g., the TCA cycle, amino acid metabolism). There is also the challenge of statistically modeling datasets with large numbers of variables but relatively small sample sizes. This perspective discusses our own experience of some of the benefits and pitfalls with using metabolomics to understand diseases associated with type 2 diabetes.</P>
]]></description>
<dc:creator><![CDATA[Griffin, J. L., Vidal-Puig, A.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00009.2008</dc:identifier>
<dc:title><![CDATA[Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding?]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>5</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>1</prism:startingPage>
<prism:section>Perspective</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/full/34/1/6?rss=1">
<title><![CDATA[SRF'ing the actin cytoskeleton with no destrin]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/full/34/1/6?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Miano, J. M.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.90243.2008</dc:identifier>
<dc:title><![CDATA[SRF'ing the actin cytoskeleton with no destrin]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>8</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>6</prism:startingPage>
<prism:section>Editorial Focus</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/9?rss=1">
<title><![CDATA[Effect of destrin mutations on the gene expression profile in vivo]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/9?rss=1</link>
<description><![CDATA[
<P>Remodeling of the actin cytoskeleton through actin dynamics (assembly and disassembly of filamentous actin) is known to be essential for numerous basic biological processes. In addition, recent studies have provided evidence that actin dynamics participate in the control of gene expression. A spontaneous mouse mutant, corneal disease 1 (<I>corn1</I>), is deficient for a regulator of actin dynamics, destrin (DSTN, also known as ADF), which causes epithelial hyperproliferation and neovascularization in the cornea. <I>Dstn</I><SUP><I>corn1</I></SUP> mice exhibit an actin dynamics defect in the corneal epithelial cells, offering an in vivo model to investigate cellular mechanisms affected by the <I>Dstn</I> mutation and resultant actin dynamics abnormalities. To examine the effect of the <I>Dstn</I><SUP><I>corn1</I></SUP> mutation on the gene expression profile, we performed a microarray analysis using the cornea from <I>Dstn</I><SUP><I>corn1</I></SUP> and wild-type mice. A dramatic alteration of the gene expression profile was observed in the <I>Dstn</I><SUP><I>corn1</I></SUP> cornea, with 1,226 annotated genes differentially expressed. Functional annotation of these genes revealed that the most significantly enriched functional categories are associated with actin and/or cytoskeleton. Among genes that belong to these categories, a considerable number of serum response factor target genes were found, indicating the possible existence of an actin-SRF pathway of transcriptional regulation in vivo. A comparative study using an allelic mutant strain with milder corneal phenotypes suggested that the level of filamentous actin may correlate with the level of gene expression changes. Our study shows that <I>Dstn</I> mutations and resultant actin dynamics abnormalities have a strong impact on the gene expression profile in vivo.</P>
]]></description>
<dc:creator><![CDATA[Verdoni, A. M., Aoyama, N., Ikeda, A., Ikeda, S.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00285.2007</dc:identifier>
<dc:title><![CDATA[Effect of destrin mutations on the gene expression profile in vivo]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>21</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>9</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/22?rss=1">
<title><![CDATA[Alternative splicing and exon duplication generates 10 unique porcine 5-HT4 receptor splice variants including a functional homofusion variant]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/22?rss=1</link>
<description><![CDATA[
<P>5-HT<SUB>4</SUB> receptors are present in human and porcine atrial myocytes while they are absent from the hearts of small laboratory animals. The pig is therefore the only available nonprimate animal model in which to study cardiac 5-HT<SUB>4</SUB> receptor function under physiological conditions. While several human splice variants of the 5-HT<SUB>4</SUB> receptor have been described, the splicing behavior of this receptor in porcine tissue is currently unknown. Here we report on the identification of nine novel COOH-terminal splice variants of the porcine 5-HT<SUB>4</SUB> receptor, which were named 5-HT<SUB>4(b2, j, k, l, m, o, p, q, r)</SUB>. The internal h-variant was found in combination with several COOH-terminal exons. In addition, splice variants were found that comprised duplicated exons fused to the common region of the 5-HT<SUB>4</SUB> receptor, thereby providing evidence for a duplication of the porcine <I>HTR4</I> gene. One of these variants putatively encoded a nine transmembrane-spanning domain homofusion receptor, 5-HT<SUB>4(9TM)</SUB>; also the other variants with a duplicated region might translate into functional, transcriptionally fused dimeric 5-HT<SUB>4</SUB> receptor variants. The elucidation of the genomic context confirmed that the variants were not genomic artefacts but originated from alternative splicing. This was further corroborated by a functional analysis of the variants 5-HT<SUB>4(a)</SUB>, 5-HT<SUB>4(r)</SUB>, and 5-HT<SUB>4(9TM)</SUB>. To our knowledge, our data are the first to report on a functional GPCR with more than seven predicted transmembrane domains. These findings urge for caution when interpreting data on 5-HT<SUB>4</SUB> receptor-related pharmacology obtained in the pig; validation at the molecular level might be needed before extrapolating results to human.</P>
]]></description>
<dc:creator><![CDATA[De Maeyer, J. H., Aerssens, J., Verhasselt, P., Lefebvre, R. A.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00038.2008</dc:identifier>
<dc:title><![CDATA[Alternative splicing and exon duplication generates 10 unique porcine 5-HT4 receptor splice variants including a functional homofusion variant]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>33</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>22</prism:startingPage>
<prism:section>Call For Papers: Comparative Genomics</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/34?rss=1">
<title><![CDATA[Functional meta-analysis of double connectivity in gene coexpression networks in mammals]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/34?rss=1</link>
<description><![CDATA[
<P>In functional genomics, the high-throughput methods such as microarrays <I>1</I>) allow analysis of the relationships between genes considering them as elements of a network and <I>2</I>) lead to biological interpretations thanks to Gene Ontology. But up to now it has not been possible to find relationships between the functions and the connectivity of the genes in coexpression networks. To achieve this aim, we have defined a double connectivity for each gene by the numbers of its significant negative and positive correlations with the other genes within a given biological condition, or group. Here, based on the analysis of 1,260 DNA microarrays, we show that this double connectivity clearly separates two types of genes, those with a predominantly strong negative connectivity, hub&ndash; genes, and those with a predominantly strong positive connectivity, hub+ genes. Interestingly, the hub+ genes concerned transcription factors more often than by chance and, similarly, for the hub&ndash; genes concerning miRNA predicted targets. Furthermore, a meta-analysis of GO annotations carried out on 67 groups in humans and rats shows that these two types of genes correspond to a functional biological duality. The hub&ndash; genes were mainly involved in basic functions common to all eukaryote cells, whereas the hub+ genes were mainly involved in specialized functions related to cell differentiation and communication. The separation and the biological role of these hub&ndash; and hub+ genes provide a powerful new tool for a better understanding of the control and regulation of the key genes involved in cellular differentiation and physiopathological conditions.</P>
]]></description>
<dc:creator><![CDATA[Gustin, M.-P., Paultre, C. Z., Randon, J., Bricca, G., Cerutti, C.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00008.2008</dc:identifier>
<dc:title><![CDATA[Functional meta-analysis of double connectivity in gene coexpression networks in mammals]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>41</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>34</prism:startingPage>
<prism:section>Call For Papers: Computational Modeling of Physiological Systems</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/42?rss=1">
<title><![CDATA[A meta-analysis of QTL for diabetes-related traits in rodents]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/42?rss=1</link>
<description><![CDATA[
<P>Crossbreeding studies in rodents have identified numerous quantitative trait loci (QTL) that are linked to diabetes-related component traits. To identify genetic consensus regions implicated in insulin action and glucose homeostasis, we have performed a meta-analysis of genomewide linkage scans for diabetes-related traits. From a total of 43 published genomewide scans we assembled a nonredundant collection of 153 QTL for glucose levels, insulin levels, and glucose tolerance. Collectively, these studies include data from 48 different parental strains and &gt;11,000 individual animals. The results of the studies were analyzed by the truncated product method (TPM). The analysis revealed significant evidence for linkage of glucose levels, insulin levels, and glucose tolerance to 27 different segments of the mouse genome. The most prominent consensus regions [localized to chromosomes 2, 4, 7, 9, 11, 13, and 19; logarithm of odds (LOD) scores 10.5&ndash;17.4] cover ~11% of the mouse genome and collectively contain the peak markers for 47 QTL. Approximately half of these genomic segments also show significant linkage to body weight and adiposity, indicating the presence of multiple obesity-dependent and -independent consensus regions for diabetes-related traits. At least 84 human genetic markers from genomewide scans and &gt;80 candidate genes from human and rodent studies map into the mouse consensus regions for diabetes-related traits, indicating a substantial overlap between the species. Our results provide guidance for the identification of novel candidate genes and demonstrate the presence of numerous distinct consensus QTL regions with highly significant LOD scores that control glucose homeostasis. An interactive physical map of the QTL is available online at <B><INTER-REF LOCATOR="http://www.diabesitygenes.org" LOCATOR-TYPE="URL">http://www.diabesitygenes.org</INTER-REF></B>.</P>
]]></description>
<dc:creator><![CDATA[Schmidt, C., Gonzaludo, N. P., Strunk, S., Dahm, S., Schuchhardt, J., Kleinjung, F., Wuschke, S., Joost, H.-G., Al-Hasani, H.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00267.2007</dc:identifier>
<dc:title><![CDATA[A meta-analysis of QTL for diabetes-related traits in rodents]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>53</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>42</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/54?rss=1">
<title><![CDATA[Molecular networks in Dahl salt-sensitive hypertension based on transcriptome analysis of a panel of consomic rats]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/54?rss=1</link>
<description><![CDATA[
<P>The Dahl salt-sensitive (SS) rat is a widely used model of human salt-sensitive hypertension and renal injury. We studied the molecular networks that underlie the complex disease phenotypes in the SS model, using a design that involved two consomic rat strains that were protected from salt-induced hypertension and one that was not protected. Substitution of Brown Norway (BN) chromosome 13 or 18, but not 20, into the SS genome was found to significantly attenuate salt-induced hypertension and albuminuria. Gene expression profiles were examined in the kidneys of SS and consomic SS-13<SUP>BN</SUP>, SS-18<SUP>BN</SUP>, and SS-20<SUP>BN</SUP> rats with a total of 240 cDNA microarrays. The substituted chromosome was overrepresented in genes differentially expressed between a consomic strain and SS rats on a 0.4% salt diet. <I>F5</I>, <I>Serpinc1</I>, <I>Slc19a2</I>, and genes represented by three other expressed sequence tags (ESTs), which are located on chromosome 13, were found to be differentially expressed between SS-13<SUP>BN</SUP> and all other strains examined. Likewise, <I>Acaa2</I>, <I>B4galt6</I>, <I>Colec12</I>, <I>Hsd17b4</I>, and five other ESTs located on chromosome 18 exhibited expression patterns unique to SS-18<SUP>BN</SUP>. On exposure to a 4% salt diet, there were 184 ESTs in the renal cortex and 346 in the renal medulla for which SS-13<SUP>BN</SUP> and SS-18<SUP>BN</SUP> shared one expression pattern, while SS and SS-20<SUP>BN</SUP> shared another, mirroring the phenotypic segregation among the four strains. Molecular networks that might contribute to the development of Dahl salt-sensitive hypertension and albuminuria were constructed with an approach that merged biological knowledge-driven analysis and data-driven Bayesian probabilistic analysis.</P>
]]></description>
<dc:creator><![CDATA[Liang, M., Lee, N. H., Wang, H., Greene, A. S., Kwitek, A. E., Kaldunski, M. L., Luu, T. V., Frank, B. C., Bugenhagen, S., Jacob, H. J., Cowley, A. W.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00031.2008</dc:identifier>
<dc:title><![CDATA[Molecular networks in Dahl salt-sensitive hypertension based on transcriptome analysis of a panel of consomic rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>64</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>54</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/65?rss=1">
<title><![CDATA[Overlapping genes in Nalp6/PYPAF5 locus encode two V2-type vasopressin isoreceptors: angiotensin-vasopressin receptor (AVR) and non-AVR]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/65?rss=1</link>
<description><![CDATA[
<P>The angiotensin-vasopressin receptor (AVR) responds with equivalent affinities to angiotensin II (ANG II) and vasopressin and is coupled to adenylate cyclase and hence a V2-type vasopressin receptor. AVR maps to the <I>Nalp6</I> locus and overlaps with the larger Nalp6/PYPAF5 reported to be a T cell/granulocyte-specific, cytoplasmic-specific proapoptotic protein, thus questioning the existence of AVR. Here we confirm, through different experimental modalities, that AVR is distinct from Nalp6/PYPAF5 based on different mRNA and protein sizes, subcellular localization, and tissue-specific expression patterns. Binding studies of PYPAF5-specific Cos1 transfectants detect high-affinity binding to vasopressin but not ANG II, thus assigning PYPAF5 as a non-AVR (NAVR). Signaling array analysis reveals that AVP stimulation of AVR- and NAVR-specific Cos1 transfectants results in diametrical activation as well as coactivation of signaling pathways known to mediate renal sodium and water balance. Likewise, ANG II stimulation of Cos1-AVR transfectants reveals a signaling profile distinct from that of AVP-stimulated Cos1-AVR transfectants. Analysis of genomic organization of the <I>AVR/NAVR</I> locus shows an overlapping gene arrangement with alternative promoter usage resulting in different NH<SUB>2</SUB> termini for NAVR and AVR. In addition to core promoter elements, androgen and estrogen response elements are detected. Promoter analysis of NAVR/AVR 5'-regulatory region detects transcriptional upregulation by testosterone and synergistic upregulation by testosterone and estrogen, thus suggesting that AVR and/or NAVR contribute to sex-specific V2-type vasopressin-mediated effects. Altogether, confirmation of AVR and identification of NAVR as vasopressin receptors are concordant with emerging vasopressin functions not attributable to V1a, V1b, or V2 receptors and add molecular bases for the multifunctional complexity of vasopressin-mediated functions and regulation.</P>
]]></description>
<dc:creator><![CDATA[Herrera, V. L. M., Bagamasbad, P., Didishvili, T., Decano, J. L., Ruiz-Opazo, N.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00199.2007</dc:identifier>
<dc:title><![CDATA[Overlapping genes in Nalp6/PYPAF5 locus encode two V2-type vasopressin isoreceptors: angiotensin-vasopressin receptor (AVR) and non-AVR]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>77</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>65</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/78?rss=1">
<title><![CDATA[Physiological and molecular evidence of heat acclimation memory: a lesson from thermal responses and ischemic cross-tolerance in the heart]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/78?rss=1</link>
<description><![CDATA[
<P>Sporadic findings in humans suggest that reinduction of heat acclimation (AC) after its loss occurs markedly faster than that during the initial AC session. Animal studies substantiated that the underlying acclimatory processes are molecular. Here we test the hypothesis that faster reinduction of AC (ReAC) implicates "molecular memory." In vivo measurements of colonic temperature profiles during heat stress and ex vivo assessment of cross-tolerance to ischemia-reperfusion or anoxia insults in the heart demonstrated that ReAC only needs 2 days vs. the 30 days required for the initial development of AC. Stress gene profiling in the experimental groups highlighted clusters of transcriptionally activated genes (37%), which included heat shock protein (HSP) genes, antiapoptotic genes, and chromatin remodeling genes. Despite a return of the physiological phenotype to its preacclimation state, after a 1 mo deacclimation (DeAC) period, the gene transcripts did not resume their preacclimation levels, suggesting a dichotomy between genotype and phenotype in this system. Individual detection of <I>hsp70</I> and <I>hsf1</I> transcripts agreed with these findings. HSP72, HSF1/P-HSF1, and Bcl-xL protein profiles followed the observed dichotomized genomic response. In contrast, HSP90, an essential cytoprotective component mismatched transcriptional activation upon DeAC. The uniform activation of the similarly responding gene clusters upon De-/ReAC implies that reacclimatory phenotypic plasticity is associated with upstream denominators. During AC, DeAC, and ReAC, the maintenance of elevated/phosphorylated HSF1 protein levels and transcriptionally active chromatin remodeling genes implies that chromatin remodeling plays a pivotal role in the transcriptome profile and in preconditioning to rapid cytoprotective acclimatory memory.</P>
]]></description>
<dc:creator><![CDATA[Tetievsky, A., Cohen, O., Eli-Berchoer, L., Gerstenblith, G., Stern, M. D., Wapinski, I., Friedman, N., Horowitz, M.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00215.2007</dc:identifier>
<dc:title><![CDATA[Physiological and molecular evidence of heat acclimation memory: a lesson from thermal responses and ischemic cross-tolerance in the heart]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>87</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>78</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/88?rss=1">
<title><![CDATA[Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/88?rss=1</link>
<description><![CDATA[
<P>Clinically, the differentiation between ischemic (ICM) and nonischemic (NICM) human cardiomyopathies is highly relevant, because ICM and NICM differ with respect to prognosis and certain aspects of pharmacological therapy, despite a common final phenotype characterized by ventricular dilatation and reduced contractility. So far, it is unclear whether microarray-based signatures can be used to infer the etiology of heart failure. Using three different classification algorithms, we independently analyzed one cDNA and two publicly available high-density oligonucleotide microarray studies comprising a total of 279 end-stage human heart failure samples. When classifiers identified in a single study were applied to the remaining studies, misclassification rates &gt;25% for ICM and NICM specimens were noted, indicating poor separation of both etiologies. However, data mining of 458 classifier genes that were concordantly identified in at least two of the three data sets points to different biological processes in ICM vs. NICM. Consistent with the underlying ischemia, cytokine signaling pathways and immediate-early response genes were overrepresented in ICM samples, whereas NICM samples displayed a deregulation of cytoskeletal transcripts, genes encoding for the major histocompatibility complex, and antigen processing and presentation pathways, potentially pointing to immunologic processes in NICM. Overall, our results suggest that ICM and NICM exhibit substantial heterogeneity at the transcriptomic level. Prospective studies are required to test whether etiology-specific gene expression patterns are present at earlier disease stages or in subsets of both etiologies.</P>
]]></description>
<dc:creator><![CDATA[Kuner, R., Barth, A. S., Ruschhaupt, M., Buness, A., Zwermann, L., Kreuzer, E., Steinbeck, G., Poustka, A., Sultmann, H., Nabauer, M.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00299.2007</dc:identifier>
<dc:title><![CDATA[Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>94</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>88</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/95?rss=1">
<title><![CDATA[Processing of naturally occurring sense/antisense transcripts of the vertebrate Slc34a gene into short RNAs]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/95?rss=1</link>
<description><![CDATA[
<P>Overlapping sense/antisense RNAs transcribed in opposite directions from the same genomic locus are common in vertebrates. The impact of antisense transcription on gene regulation and cell biology is largely unknown. We show that sense/antisense RNAs of an evolutionarily conserved phosphate transporter gene (Slc34a2a) are coexpressed in a short time window during embryonic development of zebrafish at 48 hours postfertilization (hpf). To address the mechanism by which coexpressed sense/antisense transcripts are processed, we injected sense/antisense RNAs in various combinations into <I>Xenopus</I> oocytes. In the cytoplasm RNAs were stable in whatever combination expressed. In the nucleus coinjected sense/antisense transcripts were degraded into short RNAs of ~23 bases within 4 h. A homologous transcript from toad or another isoform (Slc34a2b) from zebrafish failed to trigger processing. In oocytes that were primed with nuclear sense/antisense RNA coinjections, a reporter RNA was rapidly degraded. We produced evidence that the observed processing of complementary transcripts was not restricted to <I>Xenopus</I> oocytes, because Slc34a-related short RNAs were detected in zebrafish embryos by Northern blotting. Signals were observed at stages that showed coexpression of sense/antisense transcripts. Remarkably, strand-specific probes revealed that the orientation of short RNAs was developmentally regulated. In addition, RNA from zebrafish embryos 48 hpf was able to induce degradation of reporter constructs in <I>Xenopus</I> oocytes. Our findings may give important clues to understanding the physiological role of the widespread antisense transcription.</P>
]]></description>
<dc:creator><![CDATA[Carlile, M., Nalbant, P., Preston-Fayers, K., McHaffie, G. S., Werner, A.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00004.2008</dc:identifier>
<dc:title><![CDATA[Processing of naturally occurring sense/antisense transcripts of the vertebrate Slc34a gene into short RNAs]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>100</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>95</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/101?rss=1">
<title><![CDATA[Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/101?rss=1</link>
<description><![CDATA[
<P>Acute pulmonary embolism (PE) is the third leading cause of cardiovascular death in the United States. Moderate to severe PE can cause pulmonary arterial hypertension (PH) with resultant right ventricular (RV) heart damage. The mechanisms leading to RV failure after PE are not well defined, although it is becoming clear that PH-induced inflammatory responses are involved. We previously demonstrated profound neutrophil-mediated inflammation and RV dysfunction during PE that was associated with increased expression of several chemokine genes. However, a complete assessment of transcriptional changes in RVs during PE is still lacking. We have now used DNA microarrays to assess the alterations in gene expression in RV tissue during acute PE/PH in rats. Key results were confirmed with real-time RT-PCR. Nine CC-chemokine genes (CCL-2, -3, -4, -6, -7, -9, -17, -20, -27), five CXC-chemokine genes (CXCL-1, -2, -9, -10, -16), and the receptors CCR1 and CXCR4 were upregulated after 18 h of moderate PE, while one C-chemokine (XCL-1) and one CXC-chemokine (CXCL-12) were downregulated. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses indicated increased expression of many inflammatory genes. There was also a major shift in the expression of components of metabolic pathways, including downregulation of fatty acid transporters and oxidative enzymes, a change in glucose transporters, and upregulation of stretch-sensing and hypoxia-inducible transcription factors. This pattern suggests an extensive shift in cardiac physiology favoring the expression of the "fetal gene program."</P>
]]></description>
<dc:creator><![CDATA[Zagorski, J., Sanapareddy, N., Gellar, M. A., Kline, J. A., Watts, J. A.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00261.2007</dc:identifier>
<dc:title><![CDATA[Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>111</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>101</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/112?rss=1">
<title><![CDATA[The in vivo gene expression signature of oxidative stress]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/112?rss=1</link>
<description><![CDATA[
<P>How higher organisms respond to elevated oxidative stress in vivo is poorly understood. Therefore, we measured oxidative stress parameters and gene expression alterations (Affymetrix arrays) in the liver caused by elevated reactive oxygen species induced in vivo by diquat or by genetic ablation of the major antioxidant enzymes CuZn-superoxide dismutase (<I>Sod1</I>) and glutathione peroxidase-1 (<I>Gpx1</I>). Diquat (50 mg/kg) treatment resulted in a significant increase in oxidative damage within 3&ndash;6 h in wild-type mice without any lethality. In contrast, treatment of <I>Sod1</I><SUP>&ndash;/&ndash;</SUP> or <I>Gpx1</I><SUP>&ndash;/&ndash;</SUP> mice with a similar concentration of diquat resulted in a significant increase in oxidative damage within an hour of treatment and was lethal, i.e., these mice are extremely sensitive to the oxidative stress generated by diquat. The expression response to elevated oxidative stress in vivo does not involve an upregulation of classic antioxidant genes, although long-term oxidative stress in <I>Sod1</I><SUP>&ndash;/&ndash;</SUP> mice leads to a significant upregulation of thiol antioxidants (e.g., <I>Mt1</I>, <I>Srxn1</I>, <I>Gclc</I>, <I>Txnrd1</I>), which appears to be mediated by the redox-sensitive transcription factor <I>Nrf2</I>. The main finding of our study is that the common response to elevated oxidative stress with diquat treatment in wild-type, <I>Gpx1</I><SUP>&ndash;/&ndash;</SUP>, and <I>Sod1</I><SUP>&ndash;/&ndash;</SUP> mice and in untreated <I>Sod1</I><SUP>&ndash;/&ndash;</SUP> mice is an upregulation of p53 target genes (<I>p21</I>, <I>Gdf15</I>, <I>Plk3</I>, <I>Atf3</I>, <I>Trp53inp1</I>, <I>Ddit4</I>, <I>Gadd45a</I>, <I>Btg2</I>, <I>Ndrg1</I>). A retrospective comparison with previous studies shows that induction of these p53 target genes is a conserved expression response to oxidative stress, in vivo and in vitro, in different species and different cells/organs.</P>
]]></description>
<dc:creator><![CDATA[Han, E.-S., Muller, F. L., Perez, V. I., Qi, W., Liang, H., Xi, L., Fu, C., Doyle, E., Hickey, M., Cornell, J., Epstein, C. J., Roberts, L. J., Van Remmen, H., Richardson, A.]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00239.2007</dc:identifier>
<dc:title><![CDATA[The in vivo gene expression signature of oxidative stress]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>126</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>112</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/127?rss=1">
<title><![CDATA[Validating the genomic signature of pediatric septic shock]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/34/1/127?rss=1</link>
<description><![CDATA[
<P>We previously generated genome-wide expression data (microarray) from children with septic shock having the potential to lead the field into novel areas of investigation. Herein we seek to validate our data through a bioinformatic approach centered on a validation patient cohort. Forty-two children with a clinical diagnosis of septic shock and 15 normal controls served as the training data set, while 30 separate children with septic shock and 14 separate normal controls served as the test data set. Class prediction modeling using the training data set and the previously reported genome-wide expression signature of pediatric septic shock correctly identified 95&ndash;100% of controls and septic shock patients in the test data set, depending on the class prediction algorithm and the gene selection method. Subjecting the test data set to an identical filtering strategy as that used for the training data set, demonstrated 75% concordance between the two gene lists. Subjecting the test data set to a purely statistical filtering strategy, with highly stringent correction for multiple comparisons, demonstrated &lt;50% concordance with the previous gene filtering strategy. However, functional analysis of this statistics-based gene list demonstrated similar functional annotations and signaling pathways as that seen in the training data set. In particular, we validated that pediatric septic shock is characterized by large-scale repression of genes related to zinc homeostasis and lymphocyte function. These data demonstrate that the previously reported genome-wide expression signature of pediatric septic shock is applicable to a validation cohort of patients.</P>
]]></description>
<dc:creator><![CDATA[Cvijanovich, N., Shanley, T. P., Lin, R., Allen, G. L., Thomas, N. J., Checchia, P., Anas, N., Freishtat, R. J., Monaco, M., Odoms, K., Sakthivel, B., Wong, H. R., for the Genomics of Pediatric SIRS/Septic Shock Investigators]]></dc:creator>
<dc:date>2008-06-12</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00025.2008</dc:identifier>
<dc:title><![CDATA[Validating the genomic signature of pediatric septic shock]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>34</prism:volume>
<prism:endingPage>134</prism:endingPage>
<prism:publicationDate>2008-06-12</prism:publicationDate>
<prism:startingPage>127</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/301?rss=1">
<title><![CDATA[Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/301?rss=1</link>
<description><![CDATA[
<P>Osteoblasts are key players in bone remodeling. The accessibility of human primary osteoblast-like cells (HObs) from bone explants makes them a lucrative model for studying molecular physiology of bone turnover, for discovering novel anabolic therapeutics, and for mesenchymal cell biology in general. Relatively little is known about resting and dynamic expression profiles of HObs, and to date no studies have been conducted to systematically assess the osteoblast transcriptome. The aim of this study was to characterize HObs and investigate signaling cascades and gene networks with genomewide expression profiling in resting and bone morphogenic protein (BMP)-2- and dexamethasone-induced cells. In addition, we compared HOb gene expression with publicly available samples from the Gene Expression Omnibus. Our data show a vast number of genes and networks expressed predominantly in HObs compared with closely related cells such as fibroblasts or chondrocytes. For instance, genes in the insulin-like growth factor (IGF) signaling pathway were enriched in HObs (<I>P</I> = 0.003) and included the binding proteins (IGFBP-1, -2, -5) and IGF-II and its receptor. Another HOb-specific expression pattern included leptin and its receptor (<I>P</I> &lt; 10<SUP>&ndash;8</SUP>). Furthermore, after stimulation of HObs with BMP-2 or dexamethasone, the expression of several interesting genes and pathways was observed. For instance, our data support the role of peripheral leptin signaling in bone cell function. In conclusion, we provide the landscape of tissue-specific and dynamic gene expression in HObs. This resource will allow utilization of osteoblasts as a model to study specific gene networks and gene families related to human bone physiology and diseases.</P>
]]></description>
<dc:creator><![CDATA[Grundberg, E., Brandstrom, H., Lam, K. C. L., Gurd, S., Ge, B., Harmsen, E., Kindmark, A., Ljunggren, O., Mallmin, H., Nilsson, O., Pastinen, T.]]></dc:creator>
<dc:date>2008-05-13</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00028.2008</dc:identifier>
<dc:title><![CDATA[Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>33</prism:volume>
<prism:endingPage>311</prism:endingPage>
<prism:publicationDate>2008-05-13</prism:publicationDate>
<prism:startingPage>301</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/312?rss=1">
<title><![CDATA[Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/312?rss=1</link>
<description><![CDATA[
<P>Relaxation abnormalities are prevalent in heart failure and contribute to clinical outcomes. Disruption of Ca<SUP>2+</SUP> homeostasis in heart failure delays relaxation by prolonging the intracellular Ca<SUP>2+</SUP> transient. We sought to speed cardiac relaxation in vivo by cardiac-directed transgene expression of parvalbumin (Parv), a cytosolic Ca<SUP>2+</SUP> buffer normally expressed in fast-twitch skeletal muscle. A key feature of Parv's function resides in its Ca<SUP>2+</SUP>/Mg<SUP>2+</SUP> binding affinities that account for delayed Ca<SUP>2+</SUP> buffering in response to the intracellular Ca<SUP>2+</SUP> transient. Cardiac Parv expression decreased sarcoplasmic reticulum Ca<SUP>2+</SUP> content without otherwise altering intracellular Ca<SUP>2+</SUP> homeostasis. At high physiological mouse heart rates in vivo, Parv modestly accelerated relaxation without affecting cardiac morphology or systolic function. Ex vivo pacing of the isolated heart revealed a marked heart rate dependence of Parv's delayed Ca<SUP>2+</SUP> buffering effects on myocardial performance. As the pacing frequency was lowered (7 to 2.5 Hz), the relaxation rates increased in Parv hearts. However, as pacing rates approached the dynamic range in humans, Parv hearts demonstrated decreased contractility, consistent with Parv buffering systolic Ca<SUP>2+</SUP>. Mathematical modeling and in vitro studies provide the underlying mechanism responsible for the frequency-dependent fractional Ca<SUP>2+</SUP> buffering action of Parv. Future studies directed toward refining the dose and frequency-response relationships of Parv in the heart or engineering novel Parv-based Ca<SUP>2+</SUP> buffers with modified Mg<SUP>2+</SUP> and Ca<SUP>2+</SUP> affinities to limit systolic Ca<SUP>2+</SUP> buffering may hold promise for the development of new therapies to remediate relaxation abnormalities in heart failure.</P>
]]></description>
<dc:creator><![CDATA[Day, S. M., Coutu, P., Wang, W., Herron, T., Turner, I., Shillingford, M., LaCross, N. C., Converso, K. L., Piao, L., Li, J., Lopatin, A. N., Metzger, J. M.]]></dc:creator>
<dc:date>2008-05-13</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00302.2007</dc:identifier>
<dc:title><![CDATA[Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>33</prism:volume>
<prism:endingPage>322</prism:endingPage>
<prism:publicationDate>2008-05-13</prism:publicationDate>
<prism:startingPage>312</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/323?rss=1">
<title><![CDATA[Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/323?rss=1</link>
<description><![CDATA[
<P>Phenylethanolamine <I>N</I>-methyltransferase (PNMT) catalyzes the synthesis of epinephrine from norepinephrine. We previously identified and functionally characterized common sequence variation in the <I>PNMT</I> gene. In the present study, we set out to determine whether common <I>PNMT</I> genetic polymorphisms might be associated with individual variation in circulating epinephrine levels during exercise in 74 Caucasian American subjects. Circulating epinephrine levels were measured in each subject at baseline and during two different levels of exercise, ~40% and ~75% of peak workload. The <I>PNMT</I> gene was resequenced with DNA from each study subject. Eight novel <I>PNMT</I> polymorphisms were identified, including a C319T (Arg107Cys) nonsynonymous single nucleotide polymorphism (SNP) and I1G(280)A, a SNP located in the first intron of the gene. The I1G(280)A SNP was significantly associated with decreased exercise-induced circulating epinephrine levels and with a decreased epinephrine-to-norepinephrine ratio. The Cys107 recombinant allozyme displayed significantly lower levels of both PNMT activity and immunoreactive protein than the wild-type allozyme after transfection into COS-1 cells, but it did not appear to be associated with level of epinephrine in these subjects. Electrophoretic mobility shift and reporter gene assays performed with the I1G(280)A SNP indicated that this polymorphism could bind nuclear proteins and might modulate gene transcription. Our studies suggest that functionally significant variant sequence in the human <I>PNMT</I> gene might contribute to individual variation in levels of circulating epinephrine during exercise.</P>
]]></description>
<dc:creator><![CDATA[Ji, Y., Snyder, E. M., Fridley, B. L., Salavaggione, O. E., Moon, I., Batzler, A., Yee, V. C., Schaid, D. J., Joyner, M. J., Johnson, B. D., Weinshilboum, R. M.]]></dc:creator>
<dc:date>2008-05-13</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00248.2007</dc:identifier>
<dc:title><![CDATA[Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>33</prism:volume>
<prism:endingPage>332</prism:endingPage>
<prism:publicationDate>2008-05-13</prism:publicationDate>
<prism:startingPage>323</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/333?rss=1">
<title><![CDATA[Uncoupling protein 1 expression in murine skeletal muscle increases AMPK activation, glucose turnover, and insulin sensitivity in vivo]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/333?rss=1</link>
<description><![CDATA[
<P>Uncoupling of oxidative phosphorylation represents a potential target for the treatment of hyperglycemia and insulin resistance in obesity and type 2 diabetes. The present study investigated whether the expression of uncoupling protein 1 in skeletal muscles of transgenic (mUCP1 TG) mice modulates insulin action in major insulin target tissues in vivo. Euglycemic-hyperinsulinemic clamps (17 pM&middot;kg lean body mass<SUP>&ndash;1</SUP>&middot;min<SUP>&ndash;1</SUP>) were performed in 9-mo-old hemizygous male mUCP1 TG mice and wild-type (WT) littermates matched for body composition. mUCP1 TG mice exhibited fasting hypoglycemia and hypoinsulinemia compared with WT mice, whereas fasting hepatic glucose production rates were comparable in both genotypes. mUCP1 TG mice were markedly more sensitive to insulin action compared with WT mice and displayed threefold higher glucose infusion rates, enhanced skeletal muscle and white adipose tissue glucose uptake, and whole body glycolysis rates. In the absence of alterations in plasma adiponectin concentrations, acceleration of insulin-stimulated glucose turnover in skeletal muscle of mUCP1 TG mice was accompanied by increased phosphorylated Akt-to-Akt and phosphorylated AMP-activated protein kinase (AMPK)-to-AMPK ratios compared with WT mice. UCP1-mediated uncoupling of oxidative phosphorylation in skeletal muscle was paralleled by AMPK activation and thereby stimulated insulin-mediated glucose uptake in skeletal muscle.</P>
]]></description>
<dc:creator><![CDATA[Neschen, S., Katterle, Y., Richter, J., Augustin, R., Scherneck, S., Mirhashemi, F., Schurmann, A., Joost, H.-G., Klaus, S.]]></dc:creator>
<dc:date>2008-05-13</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00226.2007</dc:identifier>
<dc:title><![CDATA[Uncoupling protein 1 expression in murine skeletal muscle increases AMPK activation, glucose turnover, and insulin sensitivity in vivo]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>33</prism:volume>
<prism:endingPage>340</prism:endingPage>
<prism:publicationDate>2008-05-13</prism:publicationDate>
<prism:startingPage>333</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/341?rss=1">
<title><![CDATA[Transcriptional adaptation to Clcn5 knockout in proximal tubules of mouse kidney]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/341?rss=1</link>
<description><![CDATA[
<P>Dent disease has multiple defects attributed to proximal tubule malfunction including low-molecular-weight proteinuria, aminoaciduria, phosphaturia, and glycosuria. To understand the changes in kidney function of the Clc5 chloride/proton exchanger gene knockout mouse model of Dent disease, we examined gene expression profiles from proximal S1 and S2 tubules of mouse kidneys. We found many changes in gene expression not known previously to be altered in this disease. Genes involved in lipid metabolism, organ development, and organismal physiological processes had the greatest number of significantly changed transcripts. In addition, genes of catalytic activity and transporter activity also had a great number of changed transcripts. Overall, 720 genes are expressed differentially in the proximal tubules of the Dent Clcn5 knockout mouse model compared with those of control wild-type mice. The fingerprint of these gene changes may help us to understand the phenotype of Dent disease.</P>
]]></description>
<dc:creator><![CDATA[Wright, J., Morales, M. M., Sousa-Menzes, J., Ornellas, D., Sipes, J., Cui, Y., Cui, I., Hulamm, P., Cebotaru, V., Cebotaru, L., Guggino, W. B., Guggino, S. E.]]></dc:creator>
<dc:date>2008-05-13</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00024.2008</dc:identifier>
<dc:title><![CDATA[Transcriptional adaptation to Clcn5 knockout in proximal tubules of mouse kidney]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>33</prism:volume>
<prism:endingPage>354</prism:endingPage>
<prism:publicationDate>2008-05-13</prism:publicationDate>
<prism:startingPage>341</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/355?rss=1">
<title><![CDATA[Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/355?rss=1</link>
<description><![CDATA[
<P>Glucose sensing in the brain has been proposed to be involved in regulating food intake, but the mechanism is not known. Glucose transporter type 2 (GLUT2)-null mice fail to control their food intake in response to glucose, suggesting a potential role for this transporter as a glucose sensor in the brain. Here we show that individuals with a genetic variation in GLUT2 (Thr110Ile) have a higher daily intake of sugars in two distinct populations. In the first population, compared with individuals with the Thr/Thr genotype, carriers of the Ile allele had a significantly higher intake of sugars as assessed from 3-day food records administered on two separate visits (<I>visit 1</I>: 112 &plusmn; 9 vs. 86 &plusmn; 4 g/day, <I>P</I> = 0.01; <I>visit 2</I>: 111 &plusmn; 8 vs. 82 &plusmn; 4 g/day, <I>P</I> = 0.003), demonstrating within-population reproducibility. In a second population, carriers of the Ile allele also reported consuming a significantly greater intake of sugars (131 &plusmn; 5 vs. 115 &plusmn; 3 g/day, <I>P</I> = 0.007) over a 1-mo period as measured from a food frequency questionnaire. GLUT2 genotypes were not associated with fat, protein, or alcohol intake in either population. These observations were consistent across older and younger adults as well as among subjects with early Type 2 diabetes and healthy individuals. Taken together, our findings show that a genetic variation in GLUT2 is associated with habitual consumption of sugars, suggesting an underlying glucose-sensing mechanism that regulates food intake.</P>
]]></description>
<dc:creator><![CDATA[Eny, K. M., Wolever, T. M. S., Fontaine-Bisson, B., El-Sohemy, A.]]></dc:creator>
<dc:date>2008-05-13</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00148.2007</dc:identifier>
<dc:title><![CDATA[Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>33</prism:volume>
<prism:endingPage>360</prism:endingPage>
<prism:publicationDate>2008-05-13</prism:publicationDate>
<prism:startingPage>355</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

<item rdf:about="http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/361?rss=1">
<title><![CDATA[Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet]]></title>
<link>http://physiolgenomics.physiology.org/cgi/content/abstract/33/3/361?rss=1</link>
<description><![CDATA[
<P>We previously reported that mice deficient in stearoyl-CoA desaturase-1 (<I>Scd1</I>) and maintained on a very low-fat (VLF) diet for 10 days developed severe loss of body weight, hypoglycemia, hypercholesterolemia, and many cholestasis-like phenotypes. To better understand the metabolic changes associated with these phenotypes, we performed microarray analysis of hepatic gene expression in chow- and VLF-fed female <I>Scd1</I><SUP>+/+</SUP> and <I>Scd1</I><SUP>&ndash;/&ndash;</SUP> mice. We identified an extraordinary number of differentially expressed genes (&gt;4,000 probe sets) in the VLF <I>Scd1</I><SUP>&ndash;/&ndash;</SUP> relative to both VLF <I>Scd1</I><SUP>+/+</SUP> and chow <I>Scd1</I><SUP>&ndash;/&ndash;</SUP> mice. Transcript levels were reduced for genes involved in detoxification and several facets of fatty acid metabolism including biosynthesis, elongation, desaturation, oxidation, transport, and ketogenesis. This pattern is attributable to the decreased mRNA abundance of several genes encoding key transcription factors, including LXR, RXR, FXR, PPAR, PGC-1&beta;, SREBP1c, ChREBP, CAR, DBP, TEF, and HLF. A robust induction of endoplasmic reticulum (ER) stress is indicated by enhanced splicing of XBP1, increased expression of the stress-induced transcription factors CHOP and ATF3, and elevated expression of several genes involved in the integrated stress and unfolded protein response pathways. The gene expression profile is also consistent with induction of an acute inflammatory response and macrophage recruitment. These results highlight the importance of monounsaturated fatty acid synthesis for maintaining metabolic homeostasis in the absence of sufficient dietary unsaturated fat and point to a novel cellular nutrient-sensing mechanism linking fatty acid availability and/or composition to the ER stress response.</P>
]]></description>
<dc:creator><![CDATA[Flowers, M. T., Keller, M. P., Choi, Y., Lan, H., Kendziorski, C., Ntambi, J. M., Attie, A. D.]]></dc:creator>
<dc:date>2008-05-13</dc:date>
<dc:identifier>info:doi/10.1152/physiolgenomics.00139.2007</dc:identifier>
<dc:title><![CDATA[Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>33</prism:volume>
<prism:endingPage>372</prism:endingPage>
<prism:publicationDate>2008-05-13</prism:publicationDate>
<prism:startingPage>361</prism:startingPage>
<prism:section>Research Articles</prism:section>
</item>

</rdf:RDF>